Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A von Mahlangu, Johnny, Powell, Jerry S., Ragni, Margaret V., Chowdary, Pratima, Josephson, Neil C., Pabinger, Ingrid, Hanabusa, Hideji, Gupta, Naresh, Kulkarni, Roshni, Fogarty, Patrick, Perry, David, Shapiro, Amy, Pasi, K. John, Apte, Shashikant, Nestorov, Ivan, Jiang, Haiyan, Li, Shuanglian, Neelakantan, Srividya, Cristiano, Lynda M., Goyal, Jaya, Sommer, Jurg M., Dumont, Jennifer A., Dodd, Nigel, Nugent, Karen, Vigliani, Gloria, Luk, Alvin, Brennan, Aoife, Pierce, Glenn F.

Volltext

Use of Single Course IV Fludarabine in Treatment of Hypocellular Bone Marrow (Aplastic Anaemia and MDS) Patients von Apte, Shashikant J., Kelkar, Anjali J., Melinkeri, Sameer, Melinkeri, Varsha, Vaidya, Sujata, Sayaji, Bhavana

Volltext

Use of Single Course IV Fludarabine in Treatment of Hypocellular Bone Marrow (Aplastic Anaemia and MDS) Patients von Apte, Shashikant J., Vaidya, Sujata U., Shah, Nikhil, Bhatwadekar, Seema, Kalro, Akash, Sayaji, Bhavna, Suryavanshi, Prashant, Kelkar, Anjali J.

Volltext

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis von Rosendaal, Frits R., Palla, Roberta, Garagiola, Isabella, Mannucci, Pier M., Peyvandi, Flora, for the SIPPET Study Group

Volltext

An Update of Safety and Efficacy Results from Phase 1 Dose-Escalation and Expansion Study of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI), in Patients with Ch... von Cortes, Jorge E., Saikia, Tapan, Kim, Dong-Wook, Alvarado, Yesid, Nicolini, Franck E., Rathnam, Krishnakumar, Khattry, Navin, Apperley, Jane F, Deininger, Michael W., de Lavallade, Hugues, Charbonnier, Aude, Granacher, Nikki, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Mauro, Michael J., Vandenberghe, Peter, Verhoef, Gregor, Whiteley, Andrew R., Nag, Arijit, Radhakrishnan, Vivek S, Apte, Shashikant, Yao, Siu-Long, Inamdar, Sandeep, Sreenivasan, Jayasree, Dillu, Ruchika Irene, Chimote, Geetanjali

Volltext

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A von Cannavò, Antonino, Valsecchi, Carla, Garagiola, Isabella, Palla, Roberta, Mannucci, Pier Mannuccio, Rosendaal, Frits R., Peyvandi, Flora

Volltext

Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoim... von Achini‐Gutzwiller, Federica R., Snowden, John A., Corbacioglu, Selim, Greco, Raffaella, Greco, Raffaella, Alexander, Tobias, Snowden, John, Badoglio, Manuela, Labopin, Myriam, Abinun, Mario, Apte, Shashikant, Arnold, Renate, Domenech, Ariadna, Brierley, Charlotte, Burman, Joachim, Castilla‐Llorente, Cristina, Cooper, Nichola, Daghia, Giulia, Daikeler, Thomas, Papa, Nicoletta, Vries‐Bouwstra, Jeska, Farge, Dominique, Finke, Jurgen, Hagglund, Hans, Hawkey, Chris, Henes, Jörg, Hiepe, Falk, Jessop, Helen, Kiely, David, Kazmi, Majid, Kirgizov, Kirill, Kramer, Ellen, Mancardi, Gianluigi, Marjanovic, Zora, Martin, Roland, Martin, Thierry, Ma, David, Moore, John, Miller, Paul, Muraro, Paolo, Oliveira, Maria‐Carolina, Polushin, Alexey, Onida, Francesco, Simoes, Belinda, Puyade, Mathieu, Resnick, Igor, Ricart, Elena, Rovira, Montserrat, Saccardi, Riccardo, Saif, Muhammad, Sakellari, Ioanna, Sharrack, Basil, Snarski, Emilian, Scherer, Hans Ulrich, Sossa, Claudia, Withers, Barbara, Wulffraat, Nico, Zaccara, Eleanora, Amrolia, Persis, Ansari, Marc, Balduzzi, Adriana, Corbacioglu, Selim, Dalassier, Arnaud, Dalle, Jean‐Hugues, Diaz, Cristina Hereda, Feuchtinger, Tobias, Locatelli, Franco, Lucchini, Giovanna, Galimard, Jaques‐Emmanuel, Vincent, Marta Gonzalez, Handgretinger, Rupert, Kleinschmidt, Katharina, Lawitschka, Anita, Martinez, Antonio Perez, Peters, Christina, Rocha, Vanderson, Ruggeri, Annalisa, Sedlacek, Petr, Svec, Peter, Toporski, Jacek, Yesilipek, Akif

Volltext

Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopo... von Giebel, Sebastian, Labopin, Myriam, Sobczyk-Kruszelnicka, Malgorzata, Stelljes, Matthias, Byrne, Jenny L., Fegueux, Nathalie, Beelen, Dietrich W., Rovira, Montserrat, Spyridonidis, Alexandros, Blaise, Didier, Bornhäuser, Martin, Karadogan, Ihsan, Savani, Bipin N., Nagler, Arnon, Mohty, Mohamad

Volltext

Phase 1 Trial of K0706, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): In Patients with Chronic Myelogenous Leukemia (CML) and Phildelphia Positive Acute Lymphoblastic Leuk... von Cortes, Jorge E., Kim, Dong-Wook, Nicolini, Franck E, Saikia, Tapan, Charbonnier, Aude, Apperley, Jane F., Rathnam, Krishna, Deininger, Michael W., De Lavallade, Hugues, Khattry, Navin, Whiteley, Andrew, Mauro, Michael J., Verhoef, Gregor, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Apte, Shashikant, Nikki, Granacher, Yao, Siu-Long, Kothekar, Mudgal, Sreenivasan, Jayasree, HV, Bimba, Chimote, Geetanjali

Volltext

IB1001, an Investigational Recombinant Factor IX, Pharmacokinetics in Pediatric Patients with Hemophilia B von Gomperts, Edward D., Apte, Shashikant, Chaudhuri, Utpal, John, Joseph M, Ramanan, Vijay, Liesner, Ri, Shapiro, Amy D., Mills, Bonnie J., Lee, Martin

Volltext